Aluminum, Iron, and Zinc Ions Promote Aggregation of Physiological Concentrations of β‐Amyloid Peptide

Patrick W. Mantyh, Joseph R. Ghilardi, Scott Rogers, Eric DeMaster, Clark J. Allen, Evelyn R. Stimson, John E. Maggio

Research output: Contribution to journalArticlepeer-review

444 Scopus citations


Abstract: A major pathological feature of Alzheimer's disease (AD) is the presence of a high density of amyloid plaques in the brain tissue of patients. The plaques are predominantly composed of human β‐amyloid peptide βA4, a 40‐mer whose neurotoxicity is related to its aggregation. Certain metals have been proposed as risk factors for AD, but the mechanism by which the metals may exert their effects is unclear. Radioiodinated human βA4 has been used to assess the effects of various metals on the aggregation of the peptide in dilute solution (10‐10M). In physiological buffers, 10‐3M calcium, cobalt, copper, manganese, magnesium, sodium, or potassium had no effect on the rate of βA4 aggregation. In sharp contrast, aluminum, iron, and zinc under the same conditions strongly promoted aggregation (rate enhancement of 100–1,000‐fold). The aggregation of βA4 induced by aluminum and iron is distinguishable from that induced by zinc in terms of rate, extent, pH and temperature dependence. These results suggest that high concentrations of certain metals may play a role in the pathogenesis of AD by promoting aggregation of βA4.

Original languageEnglish (US)
Pages (from-to)1171-1174
Number of pages4
JournalJournal of neurochemistry
Issue number3
StatePublished - Sep 1993


  • Aluminum
  • Alzheimer's disease
  • Brain
  • Iron
  • Metal ions
  • Zinc
  • β‐Amyloid peptide

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'Aluminum, Iron, and Zinc Ions Promote Aggregation of Physiological Concentrations of β‐Amyloid Peptide'. Together they form a unique fingerprint.

Cite this